Kynam Capital Management, LP 13D and 13G filings for Olema Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 12:53 pm Sale | 2023-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA | Kynam Capital Management, LP | 0 0.000% | -2,025,234 (Position Closed) | Filing |
| 2023-03-21 5:40 pm Sale | 2022-12-30 | 13G | Olema Pharmaceuticals, Inc. OLMA | Kynam Capital Management, LP | 2,025,234 5.000% | -38,398,598 (-94.99%) | Filing |
| 2023-02-10 1:18 pm Purchase | 2022-12-30 | 13G | Olema Pharmaceuticals, Inc. OLMA | Kynam Capital Management, LP | 40,423,832 5.000% | 40,423,832 (New Position) | Filing |